NKTX Nkarta, Inc.
$1.70▼ -7.10%
Healthcare
Other
After hours
$1.68▼ -1.18%
Oct 27, 4:11 PM ET
Volume 2.52M
Avg Volume (10D) 1.22M
Key Metrics & Fundamentals
Market Cap
$121.76M
P/E Ratio
–
Div Yield
0.00%
52W Range
1.58 - 3.72
% vs 50 MA
-31.85%
% vs 200 MA
-33.10%
RSI-14
24.2
MACD Histogram
-0.0200
Beta (1Y vs SPY)
1.80
Free Cash Flow
-$24.41M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$40.40M
COGS
–
Operating Exp
$43.13M
Operating Income
-$43.13M
EBIT
-$43.13M
Pretax Income
-$40.37M
Net Income
-$40.37M
EPS (Diluted)
-0.54
Price & Volume History
Loading chart…
Recent News
Nkarta Targets ACR 2026 Data Reveal as Outpatient CAR NK Trials Advance
MarketBeat · Sep 27, 2026 3:02 PM ET
Nkarta to Participate in September Investor Conferences
GlobeNewswire · Sep 10, 2026 7:00 AM ET
Nkarta to Present Initial Autoimmune Clinical Data for NKX019 at American College of Rheumatology (ACR) Convergence 2026
GlobeNewswire · Sep 8, 2026 7:00 AM ET
Nkarta Reports Second Quarter 2026 Financial Results and Corporate Highlights
GlobeNewswire · Aug 10, 2026 4:24 PM ET
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See NKTX's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.